Posted by Michael Wonder on 02 Feb 2021
COVID‑19 vaccines – are we there yet?
1 February 2021 - The novel coronavirus SARS-CoV-2, the cause of the COVID-19 pandemic, is a highly infectious human respiratory pathogen to which the global population had no prior immunity.
The virus will likely continue to cause significant morbidity until there is a broadly effective vaccine.
As of mid December 2020, more than 200 COVID-19 vaccine candidates are in development and 11 have entered Phase 3 clinical trials globally. All generate immunity to the viral spike glycoprotein.
